Growing community of inventors

Lissieu, France

Marc Lecomte

Average Co-Inventor Count = 5.06

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Marc LecomteThierry Convard (2 patents)Marc LecomteClaude Lardy (2 patents)Marc LecomteCatherine Vidal (2 patents)Marc LecomteStéphane Yvon (1 patent)Marc LecomteDenis Descours (1 patent)Marc LecomteMichel Lagarde (1 patent)Marc LecomteNicolas Wiernsperger (1 patent)Marc LecomteUlriche Denis (1 patent)Marc LecomteClarisse Paget (1 patent)Marc LecomteMarie Noelle Denuault (1 patent)Marc LecomteMarie Noelle Denualt (0 patent)Marc LecomteMarc Lecomte (3 patents)Thierry ConvardThierry Convard (9 patents)Claude LardyClaude Lardy (8 patents)Catherine VidalCatherine Vidal (4 patents)Stéphane YvonStéphane Yvon (5 patents)Denis DescoursDenis Descours (5 patents)Michel LagardeMichel Lagarde (3 patents)Nicolas WiernspergerNicolas Wiernsperger (2 patents)Ulriche DenisUlriche Denis (1 patent)Clarisse PagetClarisse Paget (1 patent)Marie Noelle DenuaultMarie Noelle Denuault (1 patent)Marie Noelle DenualtMarie Noelle Denualt (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck Patent Gmbh (2 from 2,937 patents)

2. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)

3. Merck Sante (1 from 5 patents)


3 patents:

1. 8357721 - Specific caspase-10 inhibitors

2. 8119609 - Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors

3. 7829721 - Specific caspase-10 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…